You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA1 Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Mesothelioma
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 1, 2023

No Evidence of Disease, BRCA1 Syndrome, BRCA2 Syndrome Trial in Duarte, Los Angeles, Sylmar (questionnaire administration,

Active, not recruiting
  • No Evidence of Disease
  • +4 more
  • questionnaire administration
  • +3 more
  • Duarte, California
  • +2 more
Mar 17, 2022

Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

Active, not recruiting
  • Hereditary Breast and Ovarian Cancer
  • Structured exercise training plus mediterranean diet
  • Cologne, Germany
  • +2 more
Oct 25, 2022

Registry of Subjects at Risk of Pancreatic Cancer

Recruiting
  • Familial Pancreatic Cancer
  • +6 more
  • MRCP
  • Endoultrasonography
  • Rozzano, Milan, Italy
  • +3 more
Jan 12, 2023

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

    Completed
    • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
    • Barretos, SP, Brazil
      Barretos Cancer Hospital
    Dec 25, 2022

    Breast & Ovarian Cancer Risk Detection

    Recruiting
    • Adnexal Mass
    • +3 more
    • OVA360
    • Austin, Texas
      Silvana Franco
    Jul 20, 2022

    Hereditary Breast and Ovarian Cancer Trial in Germany (Structured exercise training plus mediterranean diet)

    Recruiting
    • Hereditary Breast and Ovarian Cancer
    • Structured exercise training plus mediterranean diet
    • Berlin, Germany
    • +18 more
    Oct 25, 2022

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    Prostatic Tumor, Prostate Cancer, BRCA2 Mutation Trial in Boston (Prostate cancer screening)

    Recruiting
    • Prostatic Neoplasm
    • +7 more
    • Prostate cancer screening
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 30, 2021

    BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome, Breast Ductal Carcinoma In Situ, Hematopoietic and Lymphoid

    Recruiting
    • BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
    • +5 more
    • Biospecimen Collection
    • +3 more
    • Portland, Oregon
    • +1 more
    Feb 9, 2022

    Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

    Not yet recruiting
    • Breast Cancer
    • Questionnaires
    • Communication of the results of the BRCA1/2 ultra rapid test
    • (no location specified)
    Oct 26, 2023

    Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

    Active, not recruiting
    • Deleterious BARD1 Gene Mutation
    • +13 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Chicago, Illinois
    • +8 more
    Feb 25, 2022

    BRCA1/2 Flu Vaccine

    Active, not recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Seasonal influenza vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 16, 2022

    Germline Variant Carriers With BRCA1 or BRCA2

    Recruiting
    • BRCA1 and/or BRCA2 Variant Carriers
    • +3 more
      • Okayama, Japan
        Okayama University
      Dec 25, 2022

      Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

      Recruiting
      • Breast Cancer
      • Genetic Predisposition
      • Genetic predisposition to breast cancer
      • Rome, Italy
      • +1 more
      May 4, 2023

      Endocrine Disruptors and Life STILe in Breast Cancer Development

      Recruiting
      • Breast Cancer
      • +5 more
        • Roma, Italy
          Alessandra Fabi
        Feb 25, 2023

        BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

        Active, not recruiting
        Has Results
        • BRCA1 Gene Mutation
        • +5 more
        • Durvalumab
        • +3 more
        • Buffalo, New York
        • +1 more
        Jan 20, 2023

        BRCA and NACT in TNBC Patients

        Completed
        • Triple-Negative Breast Cancer
        • BRCA1/2 genetic testing
        • Rome, RM, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Feb 20, 2023

        Breast Cancer BRCA1 Carriers: a Pilot Study

        Withdrawn
        • BRCA1 Mutation
        • +2 more
        • Mifepristone 200 MG
        • Prophylactic mastectomy
        • Carmel, Indiana
        • +1 more
        Dec 13, 2022

        Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

        Completed
        • Breast Cancer
        • Pegylated liposomal doxorubicin
        • Tucson, Arizona
        • +1 more
        Jan 9, 2023

        Cascade Testing in Families With Newly Diagnosed Hereditary

        Recruiting
        • BRCA-Mutated Ovarian Carcinoma
        • +7 more
        • CASCADE genetic screening
        • New York, New York
          NYU Langone Health
        Apr 30, 2021

        Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

        Active, not recruiting
        • Breast Cancer
        • +3 more
        • Boston, Massachusetts
        • +2 more
        Dec 21, 2022

        Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

        Not yet recruiting
        • Pancreatic Acinar Cell Carcinoma
        • +6 more
        • Nab paclitaxel
        • +5 more
        • (no location specified)
        Oct 30, 2023

        Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

        Not yet recruiting
        • Breast Cancer
        • +7 more
        • (no location specified)
        Sep 26, 2023